Key result
Evaluation of VWF assays in a quality assurance program revealed a 9.0% overall error rate in VWD diagnosis, with chemiluminescence-based procedures yielding the fewest errors.
Why the study?
Differentiating qualitative from quantitative von Willebrand factor defects remains problematic but carries important management implications given differential therapy.
Population
109 samples dispatched to participants representing all types of VWD, normal, and other samples
Comparison
Different VWF assays and activity/antigen ratios
Design
Proficiency testing quality assurance program study
Follow-up
25 years
Authors
Loading...
Incomplete VWF panels risk subtype misclassification in bleeding patients; leaves open optimal assay standardization.
Observational (n=1,839)
Yes
Chemiluminescence-based VWF assays demonstrate superior performance with lower variability and fewer diagnostic errors compared to traditional assays in identifying von Willebrand Disease.
Favaloro et al. (2022) conducted an observational in von Willebrand Disease (VWD) (n=1,839). von Willebrand Factor (VWF) Assays was evaluated on Identification errors. Evaluation of VWF assays in a quality assurance program revealed a 9.0% overall error rate in VWD diagnosis, with chemiluminescence-based procedures yielding the fewest errors.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: